Use of sting agonists to treat hepatitis b virus infection
AssigneeDrexel University
InventorsJINHONG CHANG, FANG GUO, TIMOTHY M. BLOCK, JU-TAO GUO
Life of this patent
Estimating the term…
Loading patent…
AssigneeDrexel University
InventorsJINHONG CHANG, FANG GUO, TIMOTHY M. BLOCK, JU-TAO GUO
Estimating the term…
The invention includes methods of treating a subject having hepatitis B viral (HBV) infection. In certain embodiments, the method of the invention comprises stimulating the innate cytokine response in macrophages, dendritic cells and/or liver non-parenchymal cells with small molecular STING agonists, thus suppressing HBV replication in hepatocytes. In other embodiments, the method of the invention can be used to treat chronic HBV infections. The invention further provides methods of identifying compounds useful in treating HBV infection in a subject.
A method of treating a subject having a hepatitis B viral (HBV) infection, the method comprising administering a pharmaceutically effective amount of a STING agonist to the subject.
A method of identifying a compound useful in treating hepatitis B virus (HBV) infection, the method comprising:
(canceled)
A method of treating a subject having a hepatitis B virus (HBV) infection, the method comprising:
Dependencies are inferred from the claim text.